Chadwick Jeremy G
Insider CIK 1388406 · KYMR Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-27 | 2026-05-27 | 3,679 | $81.50 | $299.8K | 44,618 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-27 | 2026-05-27 | 600 | $82.08 | $49.2K | 44,018 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-26 | 2026-05-27 | 4,500 | $80.02 | $360.1K | 48,848 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-26 | 2026-05-27 | 551 | $80.71 | $44.5K | 48,297 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-26 | 2026-05-27 | 3,800 | $79.39 | $301.7K | 53,348 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-26 | 2026-05-27 | 324 | $79.17 | $25.7K | 57,148 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-26 | 2026-05-27 | 3,730 | $78.36 | $292.3K | 57,472 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-22 | 2026-04-24 | 100 | — | $0 | 45,434 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-22 | 2026-04-24 | 200 | — | $0 | 58,263 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-22 | 2026-04-24 | 200 | $43.50 | $8.7K | 61,502 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-22 | 2026-04-24 | 100 | $30.17 | $3.0K | 61,302 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-22 | 2026-04-24 | 300 | $90.00 | $27.0K | 61,202 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-15 | 2026-04-16 | 1,300 | — | $0 | 58,463 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-15 | 2026-04-16 | 1,300 | $43.50 | $56.5K | 62,502 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-16 | 1,300 | $90.00 | $117.0K | 61,202 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 4,466 | — | $0 | 45,534 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 785 | — | $0 | 59,763 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 785 | $43.50 | $34.1K | 66,453 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 5,251 | $90.00 | $472.6K | 61,202 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 4,466 | $30.17 | $134.7K | 65,668 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-01 | 14,640 | — | $0 | 68,633 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-01 | 1,100 | $86.05 | $94.7K | 61,202 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-01 | 13,540 | $85.41 | $1.16M | 62,302 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-01 | 2026-04-01 | 14,640 | $29.64 | $433.9K | 75,842 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-03-31 | 2026-04-01 | 7,600 | — | $0 | 83,273 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-31 | 2026-04-01 | 7,600 | $85.38 | $648.9K | 61,202 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-03-31 | 2026-04-01 | 7,600 | $29.64 | $225.3K | 68,802 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-03-25 | 2026-03-25 | 24,727 | — | $0 | 90,873 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-25 | 2026-03-25 | 24,727 | $80.26 | $1.98M | 61,202 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-03-25 | 2026-03-25 | 24,727 | $29.64 | $732.9K | 85,929 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-03-23 | 2026-03-25 | 84,400 | — | $0 | 115,600 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-23 | 2026-03-25 | 1,200 | $80.05 | $96.1K | 61,202 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-23 | 2026-03-25 | 22,756 | $76.73 | $1.75M | 129,696 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-23 | 2026-03-25 | 52,975 | $77.21 | $4.09M | 76,721 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-23 | 2026-03-25 | 8,214 | $78.40 | $644.0K | 68,507 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-23 | 2026-03-25 | 6,105 | $79.87 | $487.6K | 62,402 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-03-23 | 2026-03-25 | 84,400 | $29.64 | $2.50M | 152,452 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-03-11 | 2026-03-11 | 20,000 | — | $0 | 60,548 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-11 | 2026-03-11 | 11,111 | $83.72 | $930.2K | 68,052 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-11 | 2026-03-11 | 12,882 | $83.10 | $1.07M | 79,163 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-11 | 2026-03-11 | 1,765 | $82.13 | $145.0K | 92,045 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-03-11 | 2026-03-11 | 20,000 | $43.50 | $870.0K | 93,810 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 394 | $84.00 | $33.1K | 77,335 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 1,150 | $85.78 | $98.6K | 74,168 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 358 | $86.62 | $31.0K | 73,810 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 2,017 | $85.04 | $171.5K | 75,318 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 25,150 | — | $0 | 25,150 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 549 | $87.75 | $48.2K | 79,219 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 383 | $88.50 | $33.9K | 78,836 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 1,107 | $89.66 | $99.3K | 77,729 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2026-03-02 | 2026-03-04 | 12,575 | — | $0 | 79,768 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-05-23 | 2025-05-23 | 2,575 | $29.30 | $75.4K | 66,420 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-03-03 | 2025-03-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2025-03-03 | 2025-03-03 | 25,000 | — | $0 | 69,183 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 252 | $31.00 | $7.8K | 67,800 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 1,131 | $30.33 | $34.3K | 68,052 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-05-23 | 2024-05-23 | 2,575 | $34.99 | $90.1K | 44,183 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 80,548 | — | $0 | 80,548 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 13,425 | — | $0 | 46,758 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-05-22 | 2023-05-22 | 200,000 | — | $0 | 200,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2023-05-22 | 2023-05-22 | 33,333 | — | $0 | 33,333 | SEC↗ |